(BAH) Booz Allen Hamilton Holding - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0995021062
AI Solutions, Cyber Solutions, Cloud Migration, Quantum Sciences
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.58% |
| Yield on Cost 5y | 2.80% |
| Yield CAGR 5y | 11.29% |
| Payout Consistency | 88.3% |
| Payout Ratio | 35.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 33.7% |
| Value at Risk 5%th | 43.0% |
| Relative Tail Risk | -22.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.01 |
| Alpha | -41.08 |
| CAGR/Max DD | -0.09 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.438 |
| Beta | 0.317 |
| Beta Downside | 0.073 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.96% |
| Mean DD | 17.54% |
| Median DD | 7.76% |
Description: BAH Booz Allen Hamilton Holding October 30, 2025
Booz Allen Hamilton Holding Corporation (NYSE: BAH) is a veteran technology and consulting firm that delivers AI-driven, cyber, and cloud-enabled solutions to U.S. cabinet-level agencies and commercial clients worldwide. Its portfolio spans purpose-built artificial-intelligence applications, cyber-defense services, legacy-system modernization, multi-modal data-fusion for ISR and battle-management, as well as emerging quantum information sciences-including quantum computing, sensing, communications, and post-quantum cryptography.
Key operating metrics highlight the firm’s scale and growth trajectory: FY 2023 revenue topped $8.1 billion, with a backlog exceeding $10 billion, indicating strong forward-order flow. AI-related services grew roughly 15 % year-over-year, outpacing the broader IT-consulting sector, while federal IT spending is projected to rise 4-5 % annually through 2028, providing a tailwind for BAH’s government contracts. Additionally, the company’s quantum-technology unit, launched in 2022, has already secured three multi-year DoD research agreements, positioning it to capture early market share as post-quantum standards evolve.
If you’re looking for a data-driven, quantitative assessment of BAH’s valuation, a quick dive into ValueRay’s analytics platform could provide the deeper insight you need.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (823.7m TTM) > 0 and > 6% of Revenue (6% = 702.3m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -1.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.85% (prev 9.12%; Δ 2.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 909.8m > Net Income 823.7m (YES >=105%, WARN >=100%) |
| Net Debt (-491.0m) to EBITDA (1.29b) ratio: -0.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (123.2m) change vs 12m ago -4.35% (target <= -2.0% for YES) |
| Gross Margin 53.45% (prev 54.77%; Δ -1.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 166.9% (prev 166.2%; Δ 0.69pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.80 (EBITDA TTM 1.29b / Interest Expense TTM 193.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.46
| (A) 0.19 = (Total Current Assets 3.22b - Total Current Liabilities 1.83b) / Total Assets 7.15b |
| (B) 0.47 = Retained Earnings (Balance) 3.38b / Total Assets 7.15b |
| (C) 0.16 = EBIT TTM 1.12b / Avg Total Assets 7.02b |
| (D) 0.54 = Book Value of Equity 3.35b / Total Liabilities 6.16b |
| Total Rating: 4.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.44
| 1. Piotroski 6.0pt |
| 2. FCF Yield 8.05% |
| 3. FCF Margin 7.00% |
| 4. Debt/Equity 0.33 |
| 5. Debt/Ebitda -0.38 |
| 6. ROIC - WACC (= 9.96)% |
| 7. RoE 77.09% |
| 8. Rev. Trend 92.87% |
| 9. EPS Trend -3.80% |
What is the price of BAH shares?
As of December 31, 2025, the stock is trading at USD 85.15 with a total of 1,297,670 shares traded.
Over the past week, the price has changed by +0.59%, over one month by +3.29%, over three months by -13.33% and over the past year by -32.21%.
Over the past week, the price has changed by +0.59%, over one month by +3.29%, over three months by -13.33% and over the past year by -32.21%.
Is BAH a buy, sell or hold?
Booz Allen Hamilton Holding has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold BAH.
- Strong Buy: 4
- Buy: 1
- Hold: 7
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the BAH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.3 | 17.8% |
| Analysts Target Price | 100.3 | 17.8% |
| ValueRay Target Price | 74.3 | -12.7% |
BAH Fundamental Data Overview December 24, 2025
Market Cap USD = 10.66b (10.66b USD * 1.0 USD.USD)
P/E Trailing = 13.006
P/E Forward = 14.2045
P/S = 0.9106
P/B = 10.3837
P/EG = 2.29
Beta = 0.338
Revenue TTM = 11.71b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.29b USD
Long Term Debt = 3.88b USD (from longTermDebt, last quarter)
Short Term Debt = 165.0m USD (from shortTermDebt, last quarter)
Debt = 325.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -491.0m USD (from netDebt column, last quarter)
Enterprise Value = 10.17b USD (10.66b + Debt 325.0m - CCE 816.0m)
Interest Coverage Ratio = 5.80 (Ebit TTM 1.12b / Interest Expense TTM 193.9m)
FCF Yield = 8.05% (FCF TTM 819.0m / Enterprise Value 10.17b)
FCF Margin = 7.00% (FCF TTM 819.0m / Revenue TTM 11.71b)
Net Margin = 7.04% (Net Income TTM 823.7m / Revenue TTM 11.71b)
Gross Margin = 53.45% ((Revenue TTM 11.71b - Cost of Revenue TTM 5.45b) / Revenue TTM)
Gross Margin QoQ = 53.63% (prev 51.33%)
Tobins Q-Ratio = 1.42 (Enterprise Value 10.17b / Total Assets 7.15b)
Interest Expense / Debt = 14.77% (Interest Expense 48.0m / Debt 325.0m)
Taxrate = 24.89% (58.0m / 233.0m)
NOPAT = 844.6m (EBIT 1.12b * (1 - 24.89%))
Current Ratio = 1.76 (Total Current Assets 3.22b / Total Current Liabilities 1.83b)
Debt / Equity = 0.33 (Debt 325.0m / totalStockholderEquity, last quarter 996.0m)
Debt / EBITDA = -0.38 (Net Debt -491.0m / EBITDA 1.29b)
Debt / FCF = -0.60 (Net Debt -491.0m / FCF TTM 819.0m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.51% (Net Income 823.7m / Total Assets 7.15b)
RoE = 77.09% (Net Income TTM 823.7m / Total Stockholder Equity 1.07b)
RoCE = 22.74% (EBIT 1.12b / Capital Employed (Equity 1.07b + L.T.Debt 3.88b))
RoIC = 17.25% (NOPAT 844.6m / Invested Capital 4.90b)
WACC = 7.30% (E(10.66b)/V(10.98b) * Re(7.18%) + D(325.0m)/V(10.98b) * Rd(14.77%) * (1-Tc(0.25)))
Discount Rate = 7.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF Debug] Terminal Value 76.27% ; FCFE base≈860.0m ; Y1≈757.0m ; Y5≈622.2m
Fair Price DCF = 93.13 (DCF Value 11.30b / Shares Outstanding 121.3m; 5y FCF grow -14.70% → 3.0% )
EPS Correlation: -3.80 | EPS CAGR: -41.20% | SUE: -4.0 | # QB: 0
Revenue Correlation: 92.87 | Revenue CAGR: 9.87% | SUE: -1.16 | # QB: 0
EPS current Year (2026-03-31): EPS=5.56 | Chg30d=-0.002 | Revisions Net=-10 | Growth EPS=-12.5% | Growth Revenue=-5.1%
EPS next Year (2027-03-31): EPS=6.05 | Chg30d=-0.009 | Revisions Net=-11 | Growth EPS=+8.9% | Growth Revenue=+2.8%
P/E Trailing = 13.006
P/E Forward = 14.2045
P/S = 0.9106
P/B = 10.3837
P/EG = 2.29
Beta = 0.338
Revenue TTM = 11.71b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.29b USD
Long Term Debt = 3.88b USD (from longTermDebt, last quarter)
Short Term Debt = 165.0m USD (from shortTermDebt, last quarter)
Debt = 325.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -491.0m USD (from netDebt column, last quarter)
Enterprise Value = 10.17b USD (10.66b + Debt 325.0m - CCE 816.0m)
Interest Coverage Ratio = 5.80 (Ebit TTM 1.12b / Interest Expense TTM 193.9m)
FCF Yield = 8.05% (FCF TTM 819.0m / Enterprise Value 10.17b)
FCF Margin = 7.00% (FCF TTM 819.0m / Revenue TTM 11.71b)
Net Margin = 7.04% (Net Income TTM 823.7m / Revenue TTM 11.71b)
Gross Margin = 53.45% ((Revenue TTM 11.71b - Cost of Revenue TTM 5.45b) / Revenue TTM)
Gross Margin QoQ = 53.63% (prev 51.33%)
Tobins Q-Ratio = 1.42 (Enterprise Value 10.17b / Total Assets 7.15b)
Interest Expense / Debt = 14.77% (Interest Expense 48.0m / Debt 325.0m)
Taxrate = 24.89% (58.0m / 233.0m)
NOPAT = 844.6m (EBIT 1.12b * (1 - 24.89%))
Current Ratio = 1.76 (Total Current Assets 3.22b / Total Current Liabilities 1.83b)
Debt / Equity = 0.33 (Debt 325.0m / totalStockholderEquity, last quarter 996.0m)
Debt / EBITDA = -0.38 (Net Debt -491.0m / EBITDA 1.29b)
Debt / FCF = -0.60 (Net Debt -491.0m / FCF TTM 819.0m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.51% (Net Income 823.7m / Total Assets 7.15b)
RoE = 77.09% (Net Income TTM 823.7m / Total Stockholder Equity 1.07b)
RoCE = 22.74% (EBIT 1.12b / Capital Employed (Equity 1.07b + L.T.Debt 3.88b))
RoIC = 17.25% (NOPAT 844.6m / Invested Capital 4.90b)
WACC = 7.30% (E(10.66b)/V(10.98b) * Re(7.18%) + D(325.0m)/V(10.98b) * Rd(14.77%) * (1-Tc(0.25)))
Discount Rate = 7.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF Debug] Terminal Value 76.27% ; FCFE base≈860.0m ; Y1≈757.0m ; Y5≈622.2m
Fair Price DCF = 93.13 (DCF Value 11.30b / Shares Outstanding 121.3m; 5y FCF grow -14.70% → 3.0% )
EPS Correlation: -3.80 | EPS CAGR: -41.20% | SUE: -4.0 | # QB: 0
Revenue Correlation: 92.87 | Revenue CAGR: 9.87% | SUE: -1.16 | # QB: 0
EPS current Year (2026-03-31): EPS=5.56 | Chg30d=-0.002 | Revisions Net=-10 | Growth EPS=-12.5% | Growth Revenue=-5.1%
EPS next Year (2027-03-31): EPS=6.05 | Chg30d=-0.009 | Revisions Net=-11 | Growth EPS=+8.9% | Growth Revenue=+2.8%
Additional Sources for BAH Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle